Table 3. Primary and delayed surgery and adjuvant therapy of study participants.
| |
Intervention group
N=178 |
Control group
N=87 |
P-value |
|---|---|---|---|
| Type of primary breast cancer surgery | |||
| Unilateral breast-conserving surgery | 76 (42.7%) | 39 (44.8%) | |
| Bilateral breast-conserving surgery | 0 (0%) | 4 (4.6%) | |
| Unilateral mastectomy | 76 (42.7%) | 35 (40.2%) | |
| Bilateral mastectomy | 26 (14.6%) | 8 (9.2%) | |
| Breast conserving on one side with a contralateral mastectomy |
0 (0%) |
1 (1.1%) |
|
| Delayed CPM |
8 (4.5%) |
5 (5.7%) |
|
| Neo-adjuvant chemotherapy | 39 (22%) | 18 (21%) | 0.80 |
| Adjuvant chemotherapy |
74 (42%) |
40 (46%) |
0.52 |
| Radiotherapy |
111 (62.3%) |
51 (58.6%) |
0.56 |
| Prophylactic salpingo-oophorectomy within 1 year follow-up |
28 (15.7%) |
9 (10.3%) |
0.24 |
| Time in days between diagnosis and primary surgery (median, range) | 36 (6–218) | ||
| Rapid test | 36 (8–197) | ||
| Semi-rapid test | 114.5 (8–242) | ||
| Routine test | 33 (9–146) | ||
Abbreviation: CPM=contralateral prophylactic mastectomy.